BlockBeats News, April 1st, Decentralized protocol Bio Protocol, focusing on early-stage biotech, announced its first major protocol upgrade on Solana and Base — Bio V1. V1 introduces several features aimed at simplifying and optimizing early-stage biotech funding and development, and introducing novel incentive mechanisms, including:
· A community-governed Launchpad for early-stage funding;
· A liquidity and incentive engine supporting immediate post-funding liquidity and rewards tied to scientific milestones;
· BioAgents, AI-driven agents capable of automating research tasks such as R&D data analysis and experimental design.
BIO token holders can determine which biotech projects get launched and their development direction. In return, they are able to access early allocations of successful projects on the network. In the screening process, BIO token holders decide which new BioDAOs can receive funding support in the Bio V1 Launchpad. By contributing BIO, participants receive discounted BioDAO tokens.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.